BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8988729)

  • 21. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
    D'Amico AV; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz SB; Tomaszewski JE; Wein A; Coleman CN
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):335-40. PubMed ID: 9308936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy.
    Green GA; Hanlon AL; Al-Saleem T; Hanks GE
    Cancer; 1998 Sep; 83(5):971-6. PubMed ID: 9731902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
    Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
    Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic postprostatectomy irradiation.
    Youssef E; Forman JD; Tekyi-Mensah S; Bolton S; Hart K
    Clin Prostate Cancer; 2002 Jun; 1(1):31-6. PubMed ID: 15046710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis.
    Lee WR; Hanks GE; Schultheiss TE; Corn BW; Hunt MA
    J Clin Oncol; 1995 Feb; 13(2):464-9. PubMed ID: 7531222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation.
    Freedman GM; Hanlon AL; Lee WR; Hanks GE
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):243-50. PubMed ID: 8635929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
    Valicenti RK; Chervoneva I; Gomella LG
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml.
    Herold D; Hanks G; Movsas B; Hanlon A
    Radiat Oncol Investig; 1997; 5(1):15-9. PubMed ID: 9303052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns and fate of PSA bouncing following 3D-CRT.
    Hanlon AL; Pinover WH; Horwitz EM; Hanks GE
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):845-9. PubMed ID: 11429210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer?
    Horwitz EM; Hanlon AL; Pinover WH; Hanks GE
    Radiat Oncol Investig; 1999; 7(4):249-59. PubMed ID: 10492166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Cancer J; 2001; 7(5):404-12. PubMed ID: 11693899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA Cheng GC; Chen MH; Whittington R; Malkowicz SB; Schnall MD; Tomaszewski JE; D'Amico AV
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):64-70. PubMed ID: 12504037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.
    D'Amico AV; Whittington R; Kaplan I; Beard C; Schultz D; Malkowicz SB; Wein A; Tomaszewski JE; Coleman CN
    Cancer; 1998 Jan; 82(2):334-41. PubMed ID: 9445191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 1989 patterns of care study for prostate cancer: five-year outcomes.
    Chuba PJ; Moughan J; Forman JD; Owen J; Hanks G
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):325-34. PubMed ID: 11380218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perineural invasion in prostatic carcinoma treated with radical prostatectomy: the role of TR systematic biopsy.
    Passavanti G; Pizzuti V; Costantini FM; Nucciotti R; Stumpo M; Paolini R
    Arch Ital Urol Androl; 2007 Mar; 79(1):23-5. PubMed ID: 17484400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Renshaw AA; Tomaszewski JE; Richie JP; Wein A
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1227-33. PubMed ID: 10613317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis.
    Livsey JE; Cowan RA; Wylie JP; Swindell R; Read G; Khoo VS; Logue JP
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1254-9. PubMed ID: 14630259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.